20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
United Therapeutics Corporation (UTHR) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Silver Spring, United States with about 1,400 employees. Its market capitalization is roughly $21 billion. In the fiscal year ended 2025-12-31, UTHR reported $3.2B in revenue and $1.3B in net income.
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally.
Interactive charts & full statements → Open the UTHR valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $3.2B | $3.2B | $2.9B | $2.3B | $1.9B | $1.7B | $1.5B | $1.4B | $1.6B | $1.7B | $1.6B | $1.5B | $1.3B | $1.1B | $916M | $743M | $604M | $370M | $281M | $211M | $160M |
| Gross Profit | $2.7B | $2.8B | $2.6B | $2.1B | $1.8B | $1.6B | $1.4B | $1.3B | $1.4B | $1.6B | $1.5B | $1.4B | $1.2B | $986M | $797M | $654M | $530M | $325M | $251M | $189M | $143M |
| Gross Margin % | 86.2% | 87.9% | 89.2% | 88.9% | 92.4% | 92.7% | 92.7% | 91.9% | 87.8% | 93.9% | 95.5% | 95.3% | 90.2% | 88.3% | 87.0% | 88.0% | 87.8% | 87.8% | 89.3% | 89.5% | 89.3% |
| Operating Income (EBIT) | $1.4B | $1.5B | $1.4B | $1.2B | $980M | $556M | $594M | ($188M) | $805M | $815M | $1.1B | $699M | $539M | $292M | $422M | $318M | $164M | $26M | ($82M) | $6M | $29M |
| Operating Margin % | 44.5% | 47.7% | 47.9% | 50.9% | 50.6% | 33.0% | 40.0% | -13.0% | 49.5% | 47.2% | 66.4% | 47.7% | 41.8% | 26.2% | 46.0% | 42.8% | 27.2% | 7.0% | -29.1% | 3.0% | 18.2% |
| Net Income | $1.3B | $1.3B | $1.2B | $985M | $727M | $476M | $515M | ($104M) | $589M | $418M | $714M | $652M | $340M | $175M | $304M | $218M | $106M | $19M | ($43M) | $20M | $74M |
| Net Margin % | 41.5% | 41.9% | 41.5% | 42.3% | 37.6% | 28.2% | 34.7% | -7.2% | 36.2% | 24.2% | 44.6% | 44.5% | 26.4% | 15.6% | 33.2% | 29.3% | 17.5% | 5.3% | -15.2% | 9.4% | 46.3% |
| EBITDA | — | $1.8B | $1.7B | $1.4B | $1.0B | $737M | $646M | ($75M) | $838M | $1.1B | $1.1B | $1.1B | $575M | $324M | $484M | $341M | $185M | $43M | ($68M) | $22M | $29M |
| Earnings Per Share (EPS) | $27.86 | $27.86 | $24.64 | $19.81 | $15.00 | $10.06 | $11.54 | $-2.39 | $13.39 | $9.31 | $15.25 | $12.72 | $6.28 | $3.28 | $5.71 | $3.67 | $1.78 | $0.35 | $-0.93 | $0.44 | $1.53 |
| Shares Outstanding (M) | — | 48M | 48M | 50M | 48M | 47M | 45M | 44M | 44M | 45M | 47M | 51M | 54M | 53M | 53M | 59M | 60M | 56M | 46M | 45M | 48M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $783M | $782M | $790M | $800M | $799M | $794M | $736M | $749M | $715M |
| Gross Profit | $684M | $648M | $687M | $699M | $711M | $702M | $660M | $666M | $637M |
| Gross Margin % | 87.4% | 82.9% | 86.9% | 87.4% | 89.0% | 88.4% | 89.7% | 88.9% | 89.1% |
| Operating Income (EBIT) | $331M | $326M | $358M | $389M | $364M | $383M | $358M | $343M | $320M |
| Operating Margin % | 42.3% | 41.7% | 45.2% | 48.7% | 45.6% | 48.2% | 48.6% | 45.8% | 44.8% |
| Net Income | $333M | $275M | $364M | $339M | $310M | $322M | $301M | $309M | $278M |
| Net Margin % | 42.5% | 35.2% | 46.1% | 42.4% | 38.8% | 40.6% | 40.9% | 41.3% | 38.9% |
| EBITDA | — | $344M | $470M | $463M | $437M | $437M | $424M | $418M | $386M |
| Earnings Per Share (EPS) | $7.27 | $5.82 | $7.61 | $7.16 | $6.41 | $6.63 | $6.19 | $6.39 | $5.85 |
| Shares Outstanding (M) | — | 47M | 48M | 47M | 48M | 49M | 49M | 48M | 48M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $1.7B | $1.6B | $1.3B | $978M | $802M | $598M | $756M | ($207M) | $778M | $474M | $644M | $383M | $355M | $425M | $324M | $250M | $212M | $100M | ($49M) | $49M | $49M |
| Capital Expenditures (CapEx) | $592M | $520M | $246M | $230M | $139M | $121M | $59M | $84M | $184M | $86M | $43M | $50M | $47M | $32M | $112M | $36M | $19M | $95M | $124M | $39M | $16M |
| Free Cash Flow (FCF) | $1.1B | $1.0B | $1.1B | $748M | $664M | $477M | $696M | ($290M) | $594M | $388M | $600M | $333M | $308M | $393M | $212M | $214M | $193M | $4M | ($174M) | $10M | $34M |
| FCF Margin % | 34.6% | 32.7% | 37.5% | 32.1% | 34.3% | 28.3% | 46.9% | -20.0% | 36.5% | 22.5% | 37.5% | 22.7% | 23.9% | 35.2% | 23.1% | 28.8% | 31.9% | 1.2% | -61.7% | 4.9% | 21.1% |
| Dividends Paid | — | — | — | $98M | $94M | — | $38M | $14M | — | $0M | $8M | $39M | $190M | $27M | $0M | $0M | $0M | — | — | $30M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $314M | $463M | $346M | $562M | $192M | $461M | $341M | $377M | $232M |
| Capital Expenditures (CapEx) | $108M | $101M | $173M | $210M | $62M | $75M | $87M | $76M | $45M |
| Free Cash Flow (FCF) | $206M | $362M | $173M | $352M | $130M | $386M | $254M | $301M | $187M |
| FCF Margin % | 26.3% | 46.4% | 21.9% | 44.0% | 16.2% | 48.6% | 34.6% | 40.2% | 26.2% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $7.2B | $7.9B | $7.4B | $7.2B | $6.0B | $5.2B | $4.6B | $3.9B | $3.4B | $2.9B | $2.3B | $2.2B | $1.9B | $2.1B | $1.6B | $1.5B | $1.4B | $1.1B | $871M | $587M | $479M |
| Cash & Cash Equivalents | $1.8B | $1.6B | $1.7B | $1.2B | $961M | $895M | $739M | $738M | $669M | $705M | $1.0B | $832M | $398M | $279M | $154M | $163M | $252M | $100M | $129M | $139M | $91M |
| Total Liabilities | $820M | $784M | $920M | $1.2B | $1.2B | $1.2B | $1.2B | $1.1B | $612M | $778M | $463M | $585M | $619M | $783M | $532M | $570M | $548M | $399M | $364M | $291M | $274M |
| Total Debt (Short + Long-Term) | — | $7M | $300M | $700M | $800M | $800M | $800M | $850M | $250M | $500M | $0M | $5M | $126M | $286M | $275M | $266M | $305M | $251M | $279M | $250M | $250M |
| Total Shareholders' Equity | $6.4B | $7.1B | $6.4B | $6.0B | $4.8B | $4.0B | $3.4B | $2.8B | $2.8B | $2.1B | $1.9B | $1.6B | $1.3B | $1.3B | $1.1B | $948M | $884M | $653M | $508M | $296M | $205M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive UTHR viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms